25 ангиотензин II рецепторни инхибитори (AIIRA), подобни рискове биха могли да съществуват при този клас медикаменти.
Unless continued ARB therapy is considered essential, patients planning pregnancy should be changed to alternative anti- hypertensive treatments which have an established safety profile for use in pregnancy.